NORCROSS, Ga., April 17, 2013 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Wednesday, April 24 at 1:00 p.m. ET to discuss its fiscal 2013 third quarter results.
Interested debt investors and analysts should contact Immucor Investor Relations at investor-requests@immucor.com or 770-441-2051 for details.
About Immucor
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. With its March 2013 acquisition of LIFECODES, Immucor entered transplant diagnostics. For more information on Immucor, please visit our website at www.immucor.com.